Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Biochemical Pharmacology|January 15, 1988
Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Lack of correlation between cellular doxorubicin levels and expression of resistanceR Ganapathi, D Grabowski
Cancer Research|August 1, 1983
Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazineR Ganapathi, D Grabowski
Biochemical Pharmacology|February 15, 1986
Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluoperazineR Ganapathi, D Grabowski, H Schmidt
British Journal of Cancer|June 1, 1993
Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotypeN Kamath, D Grabowski, J Ford, et al.
Cancer Research|November 1, 1984
Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cellsR Ganapathi, D Grabowski, W Rouse, et al.
Cancer Research|July 15, 1993
Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin)R Ganapathi, A Hercbergs, D Grabowski, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1984
Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cellsR Ganapathi, D Grabowski, R Turinic, et al.
Biochemical Pharmacology|October 1, 1990
Modulation of doxorubicin-induced chromosomal damage by calmodulin inhibitors and its relationship to cytotoxicity in progressively doxorubicin-resistant tumor cellsR Ganapathi, D Grabowski, G Hoeltge, et al.
Cancer Research|July 1, 1987
Characterization in vitro and in vivo of progressively adriamycin-resistant B16-BL6 mouse melanoma cellsR Ganapathi, D Grabowski, H Schmidt, et al.
Biochemical Pharmacology|December 24, 1996
Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylationK Kawamura, D Grabowski, K Krivacic, et al.
Pageof 18